Isotretinoin (Accutane) Dose Calculator

About the Isotretinoin (Accutane) Dose Calculator

The Isotretinoin (Accutane) Dose Calculator helps track cumulative dosing, estimate treatment duration, and monitor safety values during isotretinoin therapy. The key clinical idea is the cumulative dose target, which is usually expressed in mg/kg and used to guide how long treatment should continue.

This calculator computes the target cumulative dose from body weight, compares that target with the dose already taken, estimates the remaining treatment time at the entered daily dose, and shows common dose ranges by acne severity.

It also supports lab-review context by flagging ALT and triglyceride elevations, along with reminders about common iPLEDGE-style workflow categories and follow-up timing.

When This Page Helps

Isotretinoin treatment is usually managed around a cumulative-dose target, so it helps to see the daily dose, the target, and the remaining treatment time together. That makes it easier to follow progress without doing the arithmetic by hand.

How to Use the Inputs

1. Enter your body weight in kg or lbs
2. Enter the daily dose of isotretinoin in mg
3. Enter the number of days you have completed on treatment (0 if not yet started)
4. Set your target cumulative dose (standard: 120 mg/kg; high: 150 mg/kg)
5. Select your acne severity for dose range guidance
6. Optionally enter ALT and triglyceride values for safety monitoring
7. Review cumulative progress, remaining duration, and lab context

Example Calculation

Tips & Best Practices

• Taking isotretinoin with food usually improves absorption compared with fasting use.
• Some clinicians start with lower daily dosing early in the course to limit flare and dryness, but practice varies.
• Expect lip dryness (100% of patients) — start heavy lip balm from day 1
• Use gentle, fragrance-free moisturizers from the start (CeraVe, Vanicream, or similar)
• Avoid waxing, laser treatments, and aggressive skin procedures during treatment and 6 months after
• Alcohol use is often reviewed because liver enzymes and triglycerides may already be part of the follow-up discussion.

The Science of Cumulative Dosing

Isotretinoin's mechanism involves normalizing keratinocyte differentiation, dramatically reducing sebum production (by up to 90%), reducing Cutibacterium acnes colonization, and decreasing inflammation. The cumulative dose concept emerged from observations that relapse rates correlate inversely with total drug exposure. Strauss et al. established the 120 mg/kg guideline, but subsequent studies have shown continued benefit at higher cumulative doses.

The 120 mg/kg target represents the point where approximately 80% of patients achieve durable remission. Raising the target to 150 mg/kg improves this to approximately 85-90%. Some aggressive protocols targeting 220 mg/kg report relapse rates under 5%, though with increased side effect burden. The optimal target likely depends on individual factors including acne severity, sebum production, and response to treatment.

Managing Side Effects

Almost all patients experience mucocutaneous dryness — cheilitis (dry lips) in virtually 100%, dry skin in 50-80%, and dry eyes in 20-30%. These effects are dose-dependent and usually reversible. Moisturizers, lip care, artificial tears, and dose adjustments are common parts of follow-up discussions.

Musculoskeletal symptoms (arthralgias, myalgias, back pain) affect 15-30% of patients. Follow-up blood work is commonly reviewed early in the course, and the schedule may change later if values remain stable.

Pregnancy Prevention and iPLEDGE

Isotretinoin is a known teratogen and is contraindicated in pregnancy because fetal exposure can cause severe birth defects, miscarriage, stillbirth, and premature birth. The iPLEDGE REMS program was implemented to prevent fetal exposure and includes monthly pregnancy-testing and contraception workflow requirements for patients who can become pregnant, along with coordination between patients, prescribers, and pharmacies through a centralized online system.

Frequently Asked Questions

• What cumulative dose target should I use — 120 or 150 mg/kg?

  The traditional target of 120 mg/kg comes from early isotretinoin studies. Later publications suggested that 150 mg/kg and higher may reduce relapse rates compared with lower cumulative exposure. Some dermatologists therefore target 150-220 mg/kg for severe acne, but the exact plan remains clinician-specific.

• Does it matter if I take my dose with food?

  Yes — isotretinoin absorption nearly doubles when taken with a fatty meal (≥20g fat). Always take it with food to maximize bioavailability and reach your cumulative target more efficiently. Fasted absorption can be as low as 50% of fed absorption.

• How long is a typical course of isotretinoin?

  Most courses run 5-7 months at standard dosing (0.5-1.0 mg/kg/day). Treatment duration depends on the target cumulative dose divided by the daily dose. Lower daily doses extend the course but may have fewer side effects.

• What are the iPLEDGE requirements?

  iPLEDGE is a mandatory REMS program for isotretinoin prescribing in the US. The exact workflow depends on patient category, and the pregnancy-testing requirements apply specifically to patients who can become pregnant. This calculator only summarizes that context; it does not replace the actual program steps.

• When should I be concerned about lab results?

  Larger ALT or triglyceride elevations usually prompt prescribing-clinician review, especially when values are clearly above baseline or continue to rise. This calculator shows broad reference ranges only; actual response depends on fasting status, symptoms, baseline labs, and the treating clinician's plan.

• What about low-dose isotretinoin protocols?

  Low-dose protocols (10-20 mg/day or 0.15-0.4 mg/kg/day) are increasingly used for moderate acne and adult acne. They have fewer side effects but require longer treatment (12-18 months) to reach the same cumulative target. Efficacy appears comparable in some studies.